20:29:59 Europe / Stockholm

Prenumeration

2024-02-28 09:50:00

Redeye makes minor upwards adjustments to its fair value range following Lifecare’s year-end report 2023. With a recently reinforced balance sheet the company stands before an eventful year ahead, which should include both automated production and launch of a veterinary product.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/